Rank | Gene Set | Z-score |
---|---|---|
1 | pyrimidine nucleobase catabolic process (GO:0006208) | 7.36964615 |
2 | nucleobase catabolic process (GO:0046113) | 5.82308164 |
3 | protein-cofactor linkage (GO:0018065) | 5.81219287 |
4 | dendritic spine morphogenesis (GO:0060997) | 5.78961006 |
5 | erythrocyte maturation (GO:0043249) | 5.73804826 |
6 | cerebellar Purkinje cell layer development (GO:0021680) | 5.51273085 |
7 | vocalization behavior (GO:0071625) | 5.15538611 |
8 | central nervous system projection neuron axonogenesis (GO:0021952) | 4.65336561 |
9 | striatum development (GO:0021756) | 4.58785146 |
10 | neuron cell-cell adhesion (GO:0007158) | 4.57475866 |
11 | layer formation in cerebral cortex (GO:0021819) | 4.53887629 |
12 | positive regulation of calcium ion-dependent exocytosis (GO:0045956) | 4.46650324 |
13 | neuron recognition (GO:0008038) | 4.34636572 |
14 | synaptic vesicle exocytosis (GO:0016079) | 4.30918407 |
15 | regulation of alpha-amino-3-hydroxy-5-methyl-4-isoxazole propionate selective glutamate receptor act | 4.26232387 |
16 | growth hormone secretion (GO:0030252) | 4.19627833 |
17 | establishment of nucleus localization (GO:0040023) | 4.13252901 |
18 | axonal fasciculation (GO:0007413) | 4.08209249 |
19 | negative regulation of microtubule polymerization (GO:0031115) | 4.07312219 |
20 | regulation of synapse structural plasticity (GO:0051823) | 4.06886157 |
21 | neurofilament cytoskeleton organization (GO:0060052) | 4.06175211 |
22 | dendrite morphogenesis (GO:0048813) | 3.97277624 |
23 | protein localization to synapse (GO:0035418) | 3.93832051 |
24 | response to auditory stimulus (GO:0010996) | 3.89485884 |
25 | regulation of synaptic vesicle transport (GO:1902803) | 3.83746448 |
26 | negative regulation of dendrite development (GO:2000171) | 3.81736104 |
27 | granulocyte differentiation (GO:0030851) | 3.81093722 |
28 | positive regulation of synaptic transmission, GABAergic (GO:0032230) | 3.81086186 |
29 | negative regulation of catenin import into nucleus (GO:0035414) | 3.80966158 |
30 | regulation of glutamate receptor signaling pathway (GO:1900449) | 3.76782769 |
31 | positive regulation of excitatory postsynaptic membrane potential (GO:2000463) | 3.76676384 |
32 | eating behavior (GO:0042755) | 3.72724185 |
33 | macrophage differentiation (GO:0030225) | 3.68037078 |
34 | positive regulation of synapse assembly (GO:0051965) | 3.64467548 |
35 | regulation of telomere maintenance via telomerase (GO:0032210) | 3.61745105 |
36 | central nervous system neuron axonogenesis (GO:0021955) | 3.58904395 |
37 | clathrin coat assembly (GO:0048268) | 3.58115237 |
38 | regulation of long-term neuronal synaptic plasticity (GO:0048169) | 3.57392767 |
39 | locomotory exploration behavior (GO:0035641) | 3.55407490 |
40 | regulation of short-term neuronal synaptic plasticity (GO:0048172) | 3.54125146 |
41 | proline transport (GO:0015824) | 3.53573826 |
42 | regulation of synaptic vesicle exocytosis (GO:2000300) | 3.53555976 |
43 | synaptic vesicle endocytosis (GO:0048488) | 3.49100826 |
44 | glutamate secretion (GO:0014047) | 3.47293723 |
45 | positive regulation of action potential (GO:0045760) | 3.46574238 |
46 | ionotropic glutamate receptor signaling pathway (GO:0035235) | 3.42821513 |
47 | neurotransmitter-gated ion channel clustering (GO:0072578) | 3.37540557 |
48 | prepulse inhibition (GO:0060134) | 3.35546932 |
49 | transmission of nerve impulse (GO:0019226) | 3.29712943 |
50 | cAMP-mediated signaling (GO:0019933) | 3.27962101 |
51 | G-protein coupled acetylcholine receptor signaling pathway (GO:0007213) | 3.27789215 |
52 | positive regulation of synaptic transmission, glutamatergic (GO:0051968) | 3.24762790 |
53 | cell migration in hindbrain (GO:0021535) | 3.24332988 |
54 | response to xenobiotic stimulus (GO:0009410) | 3.19970444 |
55 | positive regulation of synaptic transmission, dopaminergic (GO:0032226) | 3.17753565 |
56 | response to misfolded protein (GO:0051788) | 3.17430508 |
57 | homophilic cell adhesion via plasma membrane adhesion molecules (GO:0007156) | 3.16976449 |
58 | auditory behavior (GO:0031223) | 3.14401972 |
59 | neurotransmitter secretion (GO:0007269) | 3.14222763 |
60 | regulation of neuronal synaptic plasticity (GO:0048168) | 3.13794796 |
61 | regulation of protein kinase A signaling (GO:0010738) | 3.12045655 |
62 | cerebellar Purkinje cell differentiation (GO:0021702) | 3.11594524 |
63 | membrane depolarization during cardiac muscle cell action potential (GO:0086012) | 3.10090740 |
64 | exploration behavior (GO:0035640) | 3.08951395 |
65 | synapse assembly (GO:0007416) | 3.08903788 |
66 | negative regulation of synaptic transmission, glutamatergic (GO:0051967) | 3.05060476 |
67 | negative regulation of synaptic transmission, GABAergic (GO:0032229) | 3.03263809 |
68 | synaptic vesicle maturation (GO:0016188) | 3.03122830 |
69 | neuron-neuron synaptic transmission (GO:0007270) | 3.02870480 |
70 | glutamate receptor signaling pathway (GO:0007215) | 3.00329312 |
71 | neuromuscular process controlling posture (GO:0050884) | 2.98767438 |
72 | synaptic transmission, dopaminergic (GO:0001963) | 2.97632543 |
73 | synaptic transmission, glutamatergic (GO:0035249) | 2.97258152 |
74 | dendritic spine organization (GO:0097061) | 2.95511028 |
75 | neuromuscular process controlling balance (GO:0050885) | 2.94938387 |
76 | neuromuscular process (GO:0050905) | 2.94737704 |
77 | dopamine receptor signaling pathway (GO:0007212) | 2.94583800 |
78 | regulation of excitatory postsynaptic membrane potential (GO:0060079) | 2.94529750 |
79 | axon extension (GO:0048675) | 2.92051006 |
80 | synapse organization (GO:0050808) | 2.91616694 |
81 | neuronal action potential propagation (GO:0019227) | 2.88429047 |
82 | positive regulation of synapse maturation (GO:0090129) | 2.87326233 |
83 | regulation of synapse assembly (GO:0051963) | 2.86759316 |
84 | activation of adenylate cyclase activity (GO:0007190) | 2.85956896 |
85 | maternal behavior (GO:0042711) | 2.85626751 |
86 | regulation of postsynaptic membrane potential (GO:0060078) | 2.85356810 |
87 | regulation of dendritic spine morphogenesis (GO:0061001) | 2.84761636 |
88 | membrane hyperpolarization (GO:0060081) | 2.83301298 |
89 | adenylate cyclase-activating dopamine receptor signaling pathway (GO:0007191) | 2.81003824 |
90 | presynaptic membrane organization (GO:0097090) | 2.79907816 |
91 | neuron remodeling (GO:0016322) | 2.78892409 |
92 | regulation of synaptic transmission, GABAergic (GO:0032228) | 2.78760439 |
93 | long-term memory (GO:0007616) | 2.78445774 |
94 | detection of temperature stimulus involved in sensory perception (GO:0050961) | 2.77681661 |
95 | detection of temperature stimulus involved in sensory perception of pain (GO:0050965) | 2.77681661 |
96 | axonogenesis (GO:0007409) | 2.76772630 |
97 | establishment of synaptic vesicle localization (GO:0097480) | 2.75227801 |
98 | synaptic vesicle transport (GO:0048489) | 2.75227801 |
99 | chaperone-mediated protein transport (GO:0072321) | 2.74714767 |
100 | negative regulation of organelle assembly (GO:1902116) | 2.74605961 |
Rank | Gene Set | Z-score |
---|---|---|
1 | EZH2_22144423_ChIP-Seq_EOC_Human | 7.90759580 |
2 | GLI1_17442700_ChIP-ChIP_MESCs_Mouse | 3.35243642 |
3 | SUZ12_18692474_ChIP-Seq_MESCs_Mouse | 3.09726806 |
4 | JARID2_20064375_ChIP-Seq_MESCs_Mouse | 3.06782346 |
5 | EZH2_27304074_Chip-Seq_ESCs_Mouse | 2.91269481 |
6 | CDKN2AIP_20523734_ChIP-Seq_CORTICAL_Neurons | 2.82462932 |
7 | TAF15_26573619_Chip-Seq_HEK293_Human | 2.81411108 |
8 | * SUZ12_18555785_ChIP-Seq_MESCs_Mouse | 2.80654478 |
9 | SUZ12_16625203_ChIP-ChIP_MESCs_Mouse | 2.75769184 |
10 | EZH2_18974828_ChIP-Seq_MESCs_Mouse | 2.68438943 |
11 | RNF2_18974828_ChIP-Seq_MESCs_Mouse | 2.68438943 |
12 | SUZ12_18974828_ChIP-Seq_MESCs_Mouse | 2.68005106 |
13 | MYCN_19997598_ChIP-ChIP_NEUROBLASTOMA_Human | 2.65309290 |
14 | GBX2_23144817_ChIP-Seq_PC3_Human | 2.62474265 |
15 | SUZ12_27294783_Chip-Seq_ESCs_Mouse | 2.59093830 |
16 | NR4A2_19515692_ChIP-ChIP_MN9D_Mouse | 2.55814485 |
17 | JARID2_20075857_ChIP-Seq_MESCs_Mouse | 2.53666273 |
18 | * SUZ12_20075857_ChIP-Seq_MESCs_Mouse | 2.46959785 |
19 | MTF2_20144788_ChIP-Seq_MESCs_Mouse | 2.43346467 |
20 | SUZ12_18692474_ChIP-Seq_MEFs_Mouse | 2.43180834 |
21 | EED_16625203_ChIP-ChIP_MESCs_Mouse | 2.42529558 |
22 | EZH2_27294783_Chip-Seq_ESCs_Mouse | 2.41470809 |
23 | ZNF274_21170338_ChIP-Seq_K562_Hela | 2.30637308 |
24 | * REST_21632747_ChIP-Seq_MESCs_Mouse | 2.26980012 |
25 | RNF2_27304074_Chip-Seq_ESCs_Mouse | 2.13975988 |
26 | REST_18959480_ChIP-ChIP_MESCs_Mouse | 2.13347664 |
27 | ZFP57_27257070_Chip-Seq_ESCs_Mouse | 2.08581352 |
28 | RNF2_27304074_Chip-Seq_NSC_Mouse | 2.00649045 |
29 | BMI1_23680149_ChIP-Seq_NPCS_Mouse | 1.94000099 |
30 | AR_21572438_ChIP-Seq_LNCaP_Human | 1.92353256 |
31 | PHC1_16625203_ChIP-ChIP_MESCs_Mouse | 1.86303497 |
32 | IKZF1_21737484_ChIP-ChIP_HCT116_Human | 1.82748290 |
33 | * CBX2_27304074_Chip-Seq_ESCs_Mouse | 1.81781958 |
34 | * RARB_27405468_Chip-Seq_BRAIN_Mouse | 1.81222845 |
35 | DROSHA_22980978_ChIP-Seq_HELA_Human | 1.77719983 |
36 | RNF2_16625203_ChIP-ChIP_MESCs_Mouse | 1.77266164 |
37 | RING1B_27294783_Chip-Seq_ESCs_Mouse | 1.67477839 |
38 | CTBP2_25329375_ChIP-Seq_LNCAP_Human | 1.64258150 |
39 | PAX3-FKHR_20663909_ChIP-Seq_RHABDOMYOSARCOMA_Human | 1.53218030 |
40 | * CTBP1_25329375_ChIP-Seq_LNCAP_Human | 1.50734064 |
41 | EZH2_23942234_ChIP-Seq_MYOBLASTS_AND_MYOTUBES_Mouse | 1.45072172 |
42 | * P300_19829295_ChIP-Seq_ESCs_Human | 1.43175770 |
43 | RING1B_27294783_Chip-Seq_NPCs_Mouse | 1.33478046 |
44 | BCL11B_21912641_ChIP-Seq_STHDH_STRIUM_Mouse | 1.27360428 |
45 | * SMARCD1_25818293_ChIP-Seq_ESCs_Mouse | 1.27069620 |
46 | ZFP322A_24550733_ChIP-Seq_MESCs_Mouse | 1.22710331 |
47 | VDR_23401126_ChIP-Seq_LCL-AND-THP1_Human | 1.21158232 |
48 | * TOP2B_26459242_ChIP-Seq_MCF-7_Human | 1.20984433 |
49 | SMAD3_21741376_ChIP-Seq_EPCs_Human | 1.19539027 |
50 | STAT3_23295773_ChIP-Seq_U87_Human | 1.18404986 |
51 | AR_25329375_ChIP-Seq_VCAP_Human | 1.17701807 |
52 | * SOX2_21211035_ChIP-Seq_LN229_Gbm | 1.17642026 |
53 | CTNNB1_20615089_ChIP-ChIP_FETAL_BRAIN_Human | 1.15102785 |
54 | RCOR2_21632747_ChIP-Seq_MESCs_Mouse | 1.13641576 |
55 | TCF3_18467660_ChIP-ChIP_MESCs_Mouse | 1.12513488 |
56 | SMAD4_21799915_ChIP-Seq_A2780_Human | 1.09630565 |
57 | TP53_20018659_ChIP-ChIP_R1E_Mouse | 1.09019078 |
58 | RUNX2_22187159_ChIP-Seq_PCA_Human | 1.06981387 |
59 | SMAD2/3_21741376_ChIP-Seq_EPCs_Human | 1.06942444 |
60 | SMARCA4_23332759_ChIP-Seq_OLIGODENDROCYTES_Mouse | 1.05880946 |
61 | RCOR3_21632747_ChIP-Seq_MESCs_Mouse | 1.05707516 |
62 | FUS_26573619_Chip-Seq_HEK293_Human | 1.05184519 |
63 | IGF1R_20145208_ChIP-Seq_DFB_Human | 1.05025048 |
64 | P53_22127205_ChIP-Seq_FIBROBLAST_Human | 1.04946859 |
65 | ELK4_26923725_Chip-Seq_MESODERM_Mouse | 1.03801574 |
66 | OLIG2_23332759_ChIP-Seq_OLIGODENDROCYTES_Mouse | 1.03696897 |
67 | PIAS1_25552417_ChIP-Seq_VCAP_Human | 1.01489467 |
68 | JUN_21703547_ChIP-Seq_K562_Human | 1.00828373 |
69 | AR_19668381_ChIP-Seq_PC3_Human | 0.99792520 |
70 | * TCF3/E2A_22897851_ChIP-Seq_JUKARTE6-1_Human | 0.99455262 |
71 | ERG_21242973_ChIP-ChIP_JURKAT_Human | 0.99041514 |
72 | UBF1/2_26484160_Chip-Seq_FIBROBLAST_Human | 0.98891650 |
73 | NR3C1_23031785_ChIP-Seq_PC12_Mouse | 0.98800605 |
74 | MEIS1_26923725_Chip-Seq_HEMOGENIC-ENDOTHELIUM_Mouse | 0.98109323 |
75 | OLIG2_26023283_ChIP-Seq_AINV15_Mouse | 0.97812146 |
76 | NR3C1_21868756_ChIP-Seq_MCF10A_Human | 0.97186445 |
77 | KDM2B_26808549_Chip-Seq_K562_Human | 0.97027241 |
78 | CTCF_27219007_Chip-Seq_Bcells_Human | 0.95926259 |
79 | DNAJC2_21179169_ChIP-ChIP_NT2_Human | 0.95838468 |
80 | KDM2B_26808549_Chip-Seq_REH_Human | 0.94255015 |
81 | YAP1_20516196_ChIP-Seq_MESCs_Mouse | 0.93586803 |
82 | ZFP281_18757296_ChIP-ChIP_E14_Mouse | 0.91973463 |
83 | WT1_20215353_ChIP-ChIP_NEPHRON_PROGENITOR_Mouse | 0.90441320 |
84 | IRF4_20064451_ChIP-Seq_CD4+T_Mouse | 0.90078273 |
85 | CBP_20019798_ChIP-Seq_JUKART_Human | 0.90078273 |
86 | SMAD3_21741376_ChIP-Seq_ESCs_Human | 0.89167463 |
87 | FOXP2_21765815_ChIP-ChIP_NEURO2A_Mouse | 0.88982676 |
88 | ARNT_22903824_ChIP-Seq_MCF-7_Human | 0.87318470 |
89 | CEBPD_23245923_ChIP-Seq_MEFs_Mouse | 0.84908410 |
90 | KLF4_25985364_ChIP-Seq_ATHEROSCLEROSIS_LESION_Mouse | 0.84284964 |
91 | POU3F2_20337985_ChIP-ChIP_501MEL_Human | 0.83989136 |
92 | CDX2_19796622_ChIP-Seq_MESCs_Mouse | 0.82714574 |
93 | * TCF4_23295773_ChIP-Seq_U87_Human | 0.82325720 |
94 | TET1_21490601_ChIP-Seq_MESCs_Mouse | 0.82196704 |
95 | * TEAD4_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 0.81938899 |
96 | * POU5F1_26923725_Chip-Seq_MESODERM_Mouse | 0.81938899 |
97 | TP53_18474530_ChIP-ChIP_U2OS_Human | 0.80273034 |
98 | * ZNF217_24962896_ChIP-Seq_MCF-7_Human | 0.80250119 |
99 | EGR1_20690147_ChIP-Seq_ERYTHROLEUKEMIA_Human | 0.79628383 |
100 | EP300_20729851_ChIP-Seq_FORBRAIN_MIDBRAIN_LIMB_HEART_Mouse | 0.79498551 |
Rank | Gene Set | Z-score |
---|---|---|
1 | MP0003880_abnormal_central_pattern | 4.53709510 |
2 | MP0004859_abnormal_synaptic_plasticity | 4.08564120 |
3 | MP0001529_abnormal_vocalization | 3.89365252 |
4 | MP0003122_maternal_imprinting | 3.88381409 |
5 | MP0006276_abnormal_autonomic_nervous | 3.69226712 |
6 | MP0004270_analgesia | 3.47710437 |
7 | MP0003635_abnormal_synaptic_transmissio | 3.39978330 |
8 | MP0009745_abnormal_behavioral_response | 3.01318115 |
9 | MP0000778_abnormal_nervous_system | 2.86110643 |
10 | MP0002063_abnormal_learning/memory/cond | 2.81188149 |
11 | MP0005423_abnormal_somatic_nervous | 2.81044303 |
12 | MP0005645_abnormal_hypothalamus_physiol | 2.79589504 |
13 | MP0003879_abnormal_hair_cell | 2.73911823 |
14 | MP0001968_abnormal_touch/_nociception | 2.70514468 |
15 | MP0001440_abnormal_grooming_behavior | 2.65053683 |
16 | MP0002064_seizures | 2.56405204 |
17 | MP0002572_abnormal_emotion/affect_behav | 2.46371350 |
18 | MP0001486_abnormal_startle_reflex | 2.33847738 |
19 | MP0002184_abnormal_innervation | 2.28075977 |
20 | MP0002734_abnormal_mechanical_nocicepti | 2.19931405 |
21 | MP0002272_abnormal_nervous_system | 2.11576704 |
22 | MP0002733_abnormal_thermal_nociception | 2.09733421 |
23 | MP0002736_abnormal_nociception_after | 2.02135882 |
24 | MP0002735_abnormal_chemical_nociception | 1.99321282 |
25 | MP0009046_muscle_twitch | 1.98467772 |
26 | MP0002822_catalepsy | 1.97627694 |
27 | MP0002909_abnormal_adrenal_gland | 1.97279834 |
28 | MP0002557_abnormal_social/conspecific_i | 1.90345587 |
29 | MP0004185_abnormal_adipocyte_glucose | 1.81012650 |
30 | MP0001970_abnormal_pain_threshold | 1.80030501 |
31 | MP0002067_abnormal_sensory_capabilities | 1.79310634 |
32 | MP0001485_abnormal_pinna_reflex | 1.74251008 |
33 | MP0004924_abnormal_behavior | 1.71740053 |
34 | MP0005386_behavior/neurological_phenoty | 1.71740053 |
35 | MP0003959_abnormal_lean_body | 1.68291538 |
36 | MP0000569_abnormal_digit_pigmentation | 1.61974152 |
37 | MP0003121_genomic_imprinting | 1.57159881 |
38 | MP0003718_maternal_effect | 1.56012876 |
39 | MP0000955_abnormal_spinal_cord | 1.48814260 |
40 | MP0002882_abnormal_neuron_morphology | 1.48646792 |
41 | MP0004811_abnormal_neuron_physiology | 1.45642926 |
42 | MP0001501_abnormal_sleep_pattern | 1.44268946 |
43 | MP0001502_abnormal_circadian_rhythm | 1.39351543 |
44 | MP0003329_amyloid_beta_deposits | 1.39128255 |
45 | MP0001905_abnormal_dopamine_level | 1.37669820 |
46 | MP0002066_abnormal_motor_capabilities/c | 1.37419081 |
47 | MP0005535_abnormal_body_temperature | 1.33356046 |
48 | MP0005646_abnormal_pituitary_gland | 1.32398534 |
49 | MP0001984_abnormal_olfaction | 1.32188790 |
50 | MP0008569_lethality_at_weaning | 1.27902840 |
51 | MP0001188_hyperpigmentation | 1.25386101 |
52 | MP0002152_abnormal_brain_morphology | 1.20239577 |
53 | MP0000751_myopathy | 1.16686558 |
54 | MP0004742_abnormal_vestibular_system | 1.16654805 |
55 | MP0004858_abnormal_nervous_system | 1.16345622 |
56 | MP0002069_abnormal_eating/drinking_beha | 1.15843724 |
57 | MP0003137_abnormal_impulse_conducting | 1.14534342 |
58 | MP0002638_abnormal_pupillary_reflex | 1.07037835 |
59 | MP0002752_abnormal_somatic_nervous | 1.03748514 |
60 | MP0000631_abnormal_neuroendocrine_gland | 1.02347906 |
61 | MP0001299_abnormal_eye_distance/ | 1.02301745 |
62 | MP0008961_abnormal_basal_metabolism | 1.00979471 |
63 | MP0004085_abnormal_heartbeat | 1.00591774 |
64 | MP0004142_abnormal_muscle_tone | 0.94018940 |
65 | MP0003861_abnormal_nervous_system | 0.91511592 |
66 | MP0001963_abnormal_hearing_physiology | 0.89196853 |
67 | MP0008995_early_reproductive_senescence | 0.86188416 |
68 | MP0003385_abnormal_body_wall | 0.86163433 |
69 | MP0010030_abnormal_orbit_morphology | 0.81429849 |
70 | MP0000026_abnormal_inner_ear | 0.78555929 |
71 | MP0003948_abnormal_gas_homeostasis | 0.77902705 |
72 | MP0004133_heterotaxia | 0.76763217 |
73 | MP0003633_abnormal_nervous_system | 0.75708477 |
74 | MP0005448_abnormal_energy_balance | 0.72510318 |
75 | MP0002229_neurodegeneration | 0.72164927 |
76 | MP0003631_nervous_system_phenotype | 0.69500936 |
77 | MP0000538_abnormal_urinary_bladder | 0.68720708 |
78 | MP0000371_diluted_coat_color | 0.68159069 |
79 | MP0005452_abnormal_adipose_tissue | 0.67629462 |
80 | MP0010770_preweaning_lethality | 0.67515635 |
81 | MP0002082_postnatal_lethality | 0.67515635 |
82 | MP0002102_abnormal_ear_morphology | 0.67230655 |
83 | MP0010769_abnormal_survival | 0.65797489 |
84 | MP0002837_dystrophic_cardiac_calcinosis | 0.64575709 |
85 | MP0005394_taste/olfaction_phenotype | 0.64171546 |
86 | MP0005499_abnormal_olfactory_system | 0.64171546 |
87 | MP0003634_abnormal_glial_cell | 0.63846351 |
88 | MP0001943_abnormal_respiration | 0.63668326 |
89 | MP0010768_mortality/aging | 0.61810091 |
90 | MP0000920_abnormal_myelination | 0.61646086 |
91 | MP0008874_decreased_physiological_sensi | 0.61614588 |
92 | MP0003953_abnormal_hormone_level | 0.59547279 |
93 | MP0005197_abnormal_uvea_morphology | 0.59409128 |
94 | MP0003956_abnormal_body_size | 0.56755429 |
95 | MP0002081_perinatal_lethality | 0.56664103 |
96 | MP0003172_abnormal_lysosome_physiology | 0.56128909 |
97 | MP0003632_abnormal_nervous_system | 0.56036723 |
98 | MP0003690_abnormal_glial_cell | 0.55986316 |
99 | MP0002751_abnormal_autonomic_nervous | 0.54805776 |
100 | MP0000604_amyloidosis | 0.53748732 |
Rank | Gene Set | Z-score |
---|---|---|
1 | Focal motor seizures (HP:0011153) | 9.55045304 |
2 | Visual hallucinations (HP:0002367) | 8.23185846 |
3 | Absence seizures (HP:0002121) | 7.15514587 |
4 | Focal seizures (HP:0007359) | 6.94446195 |
5 | Dialeptic seizures (HP:0011146) | 5.88894722 |
6 | Failure to thrive in infancy (HP:0001531) | 4.36669420 |
7 | Increased serum pyruvate (HP:0003542) | 4.31364606 |
8 | Abnormality of glycolysis (HP:0004366) | 4.31364606 |
9 | Myokymia (HP:0002411) | 4.31305370 |
10 | Polyphagia (HP:0002591) | 4.01524154 |
11 | Generalized tonic-clonic seizures (HP:0002069) | 3.44872368 |
12 | Oligomenorrhea (HP:0000876) | 3.29080041 |
13 | Abnormal eating behavior (HP:0100738) | 3.17693561 |
14 | Aplasia/Hypoplasia of the brainstem (HP:0007362) | 3.12944394 |
15 | Hypoplasia of the brainstem (HP:0002365) | 3.12944394 |
16 | Myopathic facies (HP:0002058) | 3.02005464 |
17 | Aplasia of the musculature (HP:0100854) | 2.89444479 |
18 | Sleep apnea (HP:0010535) | 2.82053480 |
19 | Amyotrophic lateral sclerosis (HP:0007354) | 2.79944398 |
20 | Atonic seizures (HP:0010819) | 2.79802459 |
21 | Limb dystonia (HP:0002451) | 2.79692326 |
22 | Neoplasm of the heart (HP:0100544) | 2.74707700 |
23 | Large eyes (HP:0001090) | 2.67506622 |
24 | Esotropia (HP:0000565) | 2.63952207 |
25 | Poor suck (HP:0002033) | 2.63001655 |
26 | Lissencephaly (HP:0001339) | 2.62923924 |
27 | Fetal akinesia sequence (HP:0001989) | 2.60971920 |
28 | Febrile seizures (HP:0002373) | 2.58902402 |
29 | Rapidly progressive (HP:0003678) | 2.53031996 |
30 | Supranuclear gaze palsy (HP:0000605) | 2.50992726 |
31 | Drooling (HP:0002307) | 2.45702201 |
32 | Excessive salivation (HP:0003781) | 2.45702201 |
33 | Deep palmar crease (HP:0006191) | 2.44537999 |
34 | Palpebral edema (HP:0100540) | 2.44008845 |
35 | Psychosis (HP:0000709) | 2.43674957 |
36 | Torticollis (HP:0000473) | 2.43291202 |
37 | Progressive cerebellar ataxia (HP:0002073) | 2.39972366 |
38 | Hypoventilation (HP:0002791) | 2.39431489 |
39 | Akinesia (HP:0002304) | 2.38333982 |
40 | Mutism (HP:0002300) | 2.33217122 |
41 | Action tremor (HP:0002345) | 2.32932825 |
42 | Ankle clonus (HP:0011448) | 2.29802016 |
43 | Abnormality of the labia minora (HP:0012880) | 2.29499731 |
44 | Anterior segment dysgenesis (HP:0007700) | 2.27686782 |
45 | Concave nail (HP:0001598) | 2.27009159 |
46 | Fair hair (HP:0002286) | 2.24884044 |
47 | Degeneration of anterior horn cells (HP:0002398) | 2.23926959 |
48 | Abnormality of the anterior horn cell (HP:0006802) | 2.23926959 |
49 | Narrow nasal bridge (HP:0000446) | 2.21022077 |
50 | Craniofacial dystonia (HP:0012179) | 2.20753796 |
51 | Depression (HP:0000716) | 2.20614501 |
52 | Blue irides (HP:0000635) | 2.18652174 |
53 | Menstrual irregularities (HP:0000858) | 2.18175974 |
54 | Aplasia/Hypoplasia involving the musculature (HP:0001460) | 2.17214262 |
55 | Focal dystonia (HP:0004373) | 2.13944715 |
56 | Generalized myoclonic seizures (HP:0002123) | 2.13124093 |
57 | Atrophy/Degeneration involving motor neurons (HP:0007373) | 2.10788661 |
58 | Partial agenesis of the corpus callosum (HP:0001338) | 2.07634161 |
59 | Truncal ataxia (HP:0002078) | 2.07180205 |
60 | Broad-based gait (HP:0002136) | 2.06729386 |
61 | Papilledema (HP:0001085) | 2.05927265 |
62 | Heterochromia iridis (HP:0001100) | 2.05833757 |
63 | Postural tremor (HP:0002174) | 2.04256494 |
64 | Progressive inability to walk (HP:0002505) | 2.04178640 |
65 | Abnormality of the lower motor neuron (HP:0002366) | 2.02603108 |
66 | Spinal canal stenosis (HP:0003416) | 2.02460684 |
67 | Pheochromocytoma (HP:0002666) | 2.00651841 |
68 | Severe muscular hypotonia (HP:0006829) | 1.97517392 |
69 | Poor eye contact (HP:0000817) | 1.96554215 |
70 | Specific learning disability (HP:0001328) | 1.95823941 |
71 | Poor speech (HP:0002465) | 1.95278818 |
72 | Iris hypopigmentation (HP:0007730) | 1.94101875 |
73 | Delayed CNS myelination (HP:0002188) | 1.94019714 |
74 | Abnormality of the astrocytes (HP:0100707) | 1.90826129 |
75 | Astrocytoma (HP:0009592) | 1.90826129 |
76 | Spastic gait (HP:0002064) | 1.89636421 |
77 | Inability to walk (HP:0002540) | 1.89532087 |
78 | Lymphangioma (HP:0100764) | 1.88738781 |
79 | Absent speech (HP:0001344) | 1.88157766 |
80 | Agitation (HP:0000713) | 1.87576463 |
81 | Microvesicular hepatic steatosis (HP:0001414) | 1.86888420 |
82 | Postural instability (HP:0002172) | 1.85151898 |
83 | Amblyopia (HP:0000646) | 1.84362548 |
84 | Abnormal social behavior (HP:0012433) | 1.83563269 |
85 | Impaired social interactions (HP:0000735) | 1.83563269 |
86 | Abnormal hair whorl (HP:0010721) | 1.82728196 |
87 | Growth hormone deficiency (HP:0000824) | 1.81573772 |
88 | Shoulder girdle muscle weakness (HP:0003547) | 1.79952105 |
89 | Epileptic encephalopathy (HP:0200134) | 1.79833428 |
90 | Bradycardia (HP:0001662) | 1.78710984 |
91 | Urinary urgency (HP:0000012) | 1.78559981 |
92 | Insidious onset (HP:0003587) | 1.77252756 |
93 | Termporal pattern (HP:0011008) | 1.77252756 |
94 | Neuroendocrine neoplasm (HP:0100634) | 1.76792361 |
95 | Lower limb asymmetry (HP:0100559) | 1.74867423 |
96 | Generalized hypopigmentation of hair (HP:0011358) | 1.73615162 |
97 | Progressive neurologic deterioration (HP:0002344) | 1.73001851 |
98 | Tongue fasciculations (HP:0001308) | 1.71947337 |
99 | Atelectasis (HP:0100750) | 1.69686554 |
100 | Gaze-evoked nystagmus (HP:0000640) | 1.69174417 |
Rank | Gene Set | Z-score |
---|---|---|
1 | SIK3 | 4.69783984 |
2 | MARK1 | 4.61016719 |
3 | MAP3K12 | 4.21986545 |
4 | NTRK2 | 3.01608557 |
5 | MINK1 | 2.80377787 |
6 | BCR | 2.74026490 |
7 | MAP3K9 | 2.45340775 |
8 | KSR1 | 2.45235267 |
9 | FGFR2 | 2.41799776 |
10 | TYRO3 | 2.37924949 |
11 | SIK2 | 2.14876380 |
12 | MAP3K4 | 2.05317323 |
13 | MAP2K4 | 1.97401639 |
14 | MAPK13 | 1.96488766 |
15 | EPHA4 | 1.92764198 |
16 | NTRK3 | 1.90745332 |
17 | UHMK1 | 1.90513792 |
18 | MAP2K7 | 1.85156052 |
19 | RIPK1 | 1.57464062 |
20 | VRK1 | 1.56692921 |
21 | PNCK | 1.56356653 |
22 | CASK | 1.55638535 |
23 | PDGFRA | 1.51611074 |
24 | CDK18 | 1.38190299 |
25 | PAK3 | 1.35575134 |
26 | PAK6 | 1.31118358 |
27 | CSNK1G2 | 1.29111212 |
28 | EPHB1 | 1.27224547 |
29 | CDK5 | 1.24097099 |
30 | CSNK1G3 | 1.23802666 |
31 | CAMK1G | 1.22696899 |
32 | DDR2 | 1.18570728 |
33 | TNIK | 1.17959552 |
34 | CDK15 | 1.16454843 |
35 | FER | 1.12020019 |
36 | DYRK2 | 1.11812287 |
37 | CDK14 | 1.10845680 |
38 | PHKG2 | 1.10434192 |
39 | PHKG1 | 1.10434192 |
40 | CSNK1A1L | 1.03939305 |
41 | LATS2 | 1.03199332 |
42 | CDK11A | 1.02060754 |
43 | NTRK1 | 0.96926095 |
44 | MAP3K11 | 0.89066050 |
45 | CSNK1G1 | 0.83607875 |
46 | EPHB2 | 0.83542913 |
47 | MARK2 | 0.82849696 |
48 | DAPK2 | 0.82333669 |
49 | FES | 0.81492194 |
50 | FGFR4 | 0.80938649 |
51 | KSR2 | 0.78583144 |
52 | TAOK1 | 0.73837687 |
53 | LIMK1 | 0.72715617 |
54 | GRK5 | 0.66590835 |
55 | RIPK4 | 0.65254721 |
56 | GRK7 | 0.65141526 |
57 | IRAK2 | 0.64832113 |
58 | CAMK2A | 0.64592590 |
59 | RPS6KA2 | 0.64173440 |
60 | PKN1 | 0.63950261 |
61 | PRKCE | 0.60994646 |
62 | PRKCG | 0.60031083 |
63 | SRPK1 | 0.59236501 |
64 | PRKCH | 0.58628106 |
65 | TAOK2 | 0.58190520 |
66 | CAMK2B | 0.57859475 |
67 | CAMK1 | 0.57586967 |
68 | MAPK10 | 0.57351560 |
69 | RET | 0.56879497 |
70 | ERBB3 | 0.56400425 |
71 | ADRBK2 | 0.53971432 |
72 | STK11 | 0.51941116 |
73 | MATK | 0.51149475 |
74 | MAPK4 | 0.50549091 |
75 | MAP3K5 | 0.49813060 |
76 | FGFR3 | 0.49077331 |
77 | WNK3 | 0.48701200 |
78 | CAMK1D | 0.48073556 |
79 | PRKACG | 0.47923732 |
80 | CAMKK1 | 0.47673591 |
81 | PRPF4B | 0.46538994 |
82 | PRKACA | 0.45736146 |
83 | ERBB2 | 0.45647207 |
84 | FYN | 0.44147918 |
85 | FGR | 0.43838362 |
86 | PRKCZ | 0.42605718 |
87 | STK39 | 0.41737260 |
88 | CAMK4 | 0.40644792 |
89 | MAPK9 | 0.40257661 |
90 | CSNK1E | 0.38895496 |
91 | PLK2 | 0.38626740 |
92 | RPS6KA3 | 0.35955498 |
93 | STK38 | 0.35810183 |
94 | PDGFRB | 0.34975492 |
95 | PRKD2 | 0.34972221 |
96 | DYRK1A | 0.34014377 |
97 | ROCK2 | 0.33376481 |
98 | SGK223 | 0.31025881 |
99 | SGK494 | 0.31025881 |
100 | PRKCB | 0.29341227 |
Rank | Gene Set | Z-score |
---|---|---|
1 | Nicotine addiction_Homo sapiens_hsa05033 | 3.21192162 |
2 | Cocaine addiction_Homo sapiens_hsa05030 | 3.01240701 |
3 | Synaptic vesicle cycle_Homo sapiens_hsa04721 | 2.63539426 |
4 | GABAergic synapse_Homo sapiens_hsa04727 | 2.61073291 |
5 | Terpenoid backbone biosynthesis_Homo sapiens_hsa00900 | 2.49828386 |
6 | Axon guidance_Homo sapiens_hsa04360 | 2.46083542 |
7 | Morphine addiction_Homo sapiens_hsa05032 | 2.44803327 |
8 | Dopaminergic synapse_Homo sapiens_hsa04728 | 2.35769610 |
9 | Glutamatergic synapse_Homo sapiens_hsa04724 | 2.33107096 |
10 | Olfactory transduction_Homo sapiens_hsa04740 | 2.28814381 |
11 | Insulin secretion_Homo sapiens_hsa04911 | 2.22753536 |
12 | Retrograde endocannabinoid signaling_Homo sapiens_hsa04723 | 2.21166196 |
13 | Circadian entrainment_Homo sapiens_hsa04713 | 2.17229310 |
14 | Amphetamine addiction_Homo sapiens_hsa05031 | 2.10131910 |
15 | Endocrine and other factor-regulated calcium reabsorption_Homo sapiens_hsa04961 | 2.07042041 |
16 | Serotonergic synapse_Homo sapiens_hsa04726 | 1.74134067 |
17 | Aldosterone synthesis and secretion_Homo sapiens_hsa04925 | 1.69085359 |
18 | Cardiac muscle contraction_Homo sapiens_hsa04260 | 1.66470982 |
19 | Adrenergic signaling in cardiomyocytes_Homo sapiens_hsa04261 | 1.65261829 |
20 | Long-term potentiation_Homo sapiens_hsa04720 | 1.63166113 |
21 | Gap junction_Homo sapiens_hsa04540 | 1.61762008 |
22 | Vasopressin-regulated water reabsorption_Homo sapiens_hsa04962 | 1.60309973 |
23 | Salivary secretion_Homo sapiens_hsa04970 | 1.52391415 |
24 | Cholinergic synapse_Homo sapiens_hsa04725 | 1.50437458 |
25 | Nitrogen metabolism_Homo sapiens_hsa00910 | 1.43943438 |
26 | Taste transduction_Homo sapiens_hsa04742 | 1.42092265 |
27 | Neuroactive ligand-receptor interaction_Homo sapiens_hsa04080 | 1.40113382 |
28 | GnRH signaling pathway_Homo sapiens_hsa04912 | 1.36555167 |
29 | Parkinsons disease_Homo sapiens_hsa05012 | 1.35802069 |
30 | Renin secretion_Homo sapiens_hsa04924 | 1.35793461 |
31 | Inflammatory mediator regulation of TRP channels_Homo sapiens_hsa04750 | 1.33324882 |
32 | Synthesis and degradation of ketone bodies_Homo sapiens_hsa00072 | 1.32038875 |
33 | Gastric acid secretion_Homo sapiens_hsa04971 | 1.29310329 |
34 | Long-term depression_Homo sapiens_hsa04730 | 1.27083900 |
35 | Calcium signaling pathway_Homo sapiens_hsa04020 | 1.22427553 |
36 | Glycosaminoglycan biosynthesis - heparan sulfate / heparin_Homo sapiens_hsa00534 | 1.21760482 |
37 | Oxytocin signaling pathway_Homo sapiens_hsa04921 | 1.21564539 |
38 | Other types of O-glycan biosynthesis_Homo sapiens_hsa00514 | 1.21093402 |
39 | Taurine and hypotaurine metabolism_Homo sapiens_hsa00430 | 1.10250502 |
40 | Alzheimers disease_Homo sapiens_hsa05010 | 1.08324755 |
41 | Alcoholism_Homo sapiens_hsa05034 | 1.01745831 |
42 | Alanine, aspartate and glutamate metabolism_Homo sapiens_hsa00250 | 1.01099650 |
43 | cAMP signaling pathway_Homo sapiens_hsa04024 | 1.00327016 |
44 | Estrogen signaling pathway_Homo sapiens_hsa04915 | 0.99514918 |
45 | Oxidative phosphorylation_Homo sapiens_hsa00190 | 0.97336266 |
46 | Cell adhesion molecules (CAMs)_Homo sapiens_hsa04514 | 0.97169680 |
47 | ErbB signaling pathway_Homo sapiens_hsa04012 | 0.96176613 |
48 | Phenylalanine, tyrosine and tryptophan biosynthesis_Homo sapiens_hsa00400 | 0.95304188 |
49 | Epithelial cell signaling in Helicobacter pylori infection_Homo sapiens_hsa05120 | 0.91061144 |
50 | Collecting duct acid secretion_Homo sapiens_hsa04966 | 0.89267767 |
51 | Phototransduction_Homo sapiens_hsa04744 | 0.87941259 |
52 | Arrhythmogenic right ventricular cardiomyopathy (ARVC)_Homo sapiens_hsa05412 | 0.83064735 |
53 | MAPK signaling pathway_Homo sapiens_hsa04010 | 0.81099515 |
54 | Phospholipase D signaling pathway_Homo sapiens_hsa04072 | 0.79167679 |
55 | Melanogenesis_Homo sapiens_hsa04916 | 0.77734906 |
56 | Choline metabolism in cancer_Homo sapiens_hsa05231 | 0.77320478 |
57 | Fc epsilon RI signaling pathway_Homo sapiens_hsa04664 | 0.75151154 |
58 | Phosphatidylinositol signaling system_Homo sapiens_hsa04070 | 0.73673550 |
59 | Colorectal cancer_Homo sapiens_hsa05210 | 0.73424061 |
60 | Pathogenic Escherichia coli infection_Homo sapiens_hsa05130 | 0.73321938 |
61 | Dilated cardiomyopathy_Homo sapiens_hsa05414 | 0.73061716 |
62 | Butanoate metabolism_Homo sapiens_hsa00650 | 0.72744109 |
63 | Thyroid hormone synthesis_Homo sapiens_hsa04918 | 0.71254455 |
64 | Proximal tubule bicarbonate reclamation_Homo sapiens_hsa04964 | 0.70712482 |
65 | Vibrio cholerae infection_Homo sapiens_hsa05110 | 0.70316370 |
66 | Glycosaminoglycan biosynthesis - keratan sulfate_Homo sapiens_hsa00533 | 0.69273247 |
67 | Arginine biosynthesis_Homo sapiens_hsa00220 | 0.62721668 |
68 | Glioma_Homo sapiens_hsa05214 | 0.62588550 |
69 | Oocyte meiosis_Homo sapiens_hsa04114 | 0.61007677 |
70 | Type II diabetes mellitus_Homo sapiens_hsa04930 | 0.60368994 |
71 | Wnt signaling pathway_Homo sapiens_hsa04310 | 0.59952186 |
72 | Sphingolipid signaling pathway_Homo sapiens_hsa04071 | 0.56390006 |
73 | Huntingtons disease_Homo sapiens_hsa05016 | 0.54645103 |
74 | Neurotrophin signaling pathway_Homo sapiens_hsa04722 | 0.53393023 |
75 | Dorso-ventral axis formation_Homo sapiens_hsa04320 | 0.53380950 |
76 | Pancreatic secretion_Homo sapiens_hsa04972 | 0.53141845 |
77 | cGMP-PKG signaling pathway_Homo sapiens_hsa04022 | 0.51640277 |
78 | Prion diseases_Homo sapiens_hsa05020 | 0.50422561 |
79 | Biosynthesis of unsaturated fatty acids_Homo sapiens_hsa01040 | 0.50201075 |
80 | Aldosterone-regulated sodium reabsorption_Homo sapiens_hsa04960 | 0.49573107 |
81 | Endometrial cancer_Homo sapiens_hsa05213 | 0.48364460 |
82 | Viral myocarditis_Homo sapiens_hsa05416 | 0.47662332 |
83 | Glycosphingolipid biosynthesis - lacto and neolacto series_Homo sapiens_hsa00601 | 0.47468593 |
84 | Ubiquitin mediated proteolysis_Homo sapiens_hsa04120 | 0.47398301 |
85 | Hypertrophic cardiomyopathy (HCM)_Homo sapiens_hsa05410 | 0.45673049 |
86 | Amyotrophic lateral sclerosis (ALS)_Homo sapiens_hsa05014 | 0.44731235 |
87 | Rap1 signaling pathway_Homo sapiens_hsa04015 | 0.43591390 |
88 | Ras signaling pathway_Homo sapiens_hsa04014 | 0.43296515 |
89 | Renin-angiotensin system_Homo sapiens_hsa04614 | 0.42327376 |
90 | Basal cell carcinoma_Homo sapiens_hsa05217 | 0.41312693 |
91 | Thyroid hormone signaling pathway_Homo sapiens_hsa04919 | 0.40881086 |
92 | VEGF signaling pathway_Homo sapiens_hsa04370 | 0.40599534 |
93 | Vascular smooth muscle contraction_Homo sapiens_hsa04270 | 0.39796736 |
94 | Bile secretion_Homo sapiens_hsa04976 | 0.37293180 |
95 | Glucagon signaling pathway_Homo sapiens_hsa04922 | 0.36477628 |
96 | Sulfur relay system_Homo sapiens_hsa04122 | 0.35600194 |
97 | Type I diabetes mellitus_Homo sapiens_hsa04940 | 0.34826438 |
98 | Inositol phosphate metabolism_Homo sapiens_hsa00562 | 0.33879368 |
99 | Endocytosis_Homo sapiens_hsa04144 | 0.33463326 |
100 | Renal cell carcinoma_Homo sapiens_hsa05211 | 0.31784781 |